bioRxiv Science⌕ Search

Biology subjects

Cereda, M.

Publications and source records attributed to Cereda, M..

6 recordsLinked to original sources

KDM: embedding DNA/RNA motifs and sequences in a shared k-mer space for unified discovery, analysis and binding prediction

Motif discovery and binding-site prediction in DNA and RNA sequences are central tasks in regulatory genomics, yet the methodological landscape is split between interpretable but rigid position weight matrices (PWMs) and high-performing but opaque machine-learning models. We present KDM, a unifying framework in which both motifs and sequences are represented as probability distributions over a shared k-mer dictionary, embedded via the Hellinger transformation. This common geometry enables motif-sequence scoring, motif-motif comparison, de novo discovery, and binding prediction with a single primitive, the Bhattacharyya coefficient. We instantiate four tools on this representation: KDMMap for positional enrichment analysis, KDMMatch for information-content-aware motif matching, KDMFind for unsupervised motif discovery via projective non-negative matrix factorization, and KDM-LRLM for binding prediction with Lasso-regularized logistic regression. Across 1,324 transcription-factor ChIP-seq and 161 RBP eCLIP experiments, KDMMap matches CentriMos motif rankings in 84% of TF and 79% of RBP experiments, and KDMMatch agrees with Tomtom on motif annotation in 74.5% of TFs. On binding prediction across four datasets covering 2,475 experiments, KDM-LRLM matches or exceeds eight deep-learning and three k-mer-based competitors. Notably, AI methods overtake k-mer methods only in the top quartile of training-set size, indicating that data scale, not architecture, drives the recent dominance of deep models. KDM provides a single interpretable representation across the full motif-analysis workflow.

bioinformatics↗

RNAMaRs: an interpretable framework for inferring multivalent RNA Motifs and cognate Regulators of Splicing

Alternative splicing expands proteomic diversity and is shaped by interactions between RNA-binding proteins (RBPs) and multivalent RNA motifs. Linking sequence elements to regulatory proteins remains difficult from sequence information alone. Here we present RNAMaRs, a interpretable statistical framework that combines motif discovery with in vivo binding and splicing responses to infer motif-RBP relationships. RNAMaRs learns RBP binding principles, weights signal quality, and optimizes motif discovery in an RBP-specific manner. Across ENCODE datasets RNAMaRs consistently prioritizes the perturbed regulator, especially for large splicing effects. Independent validation in prostate cancer cells recapitulates HNRNPK binding signatures, supporting transferability across an unseen cellular context.

molecular biology↗

Kandinsky: enabling neighbourhood analysis of spatial omics data for functional insights on cell ecosystems

Spatially resolved omics technologies enable investigation of how cells interact within their local environments or neighbourhoods directly in situ. Although a few computational methods have been developed to aid this analysis, significant limitations still exist in the way neighbourhoods are defined and exploited for downstream analyses. Here, we present Kandinsky, a computational tool that implements multiple approaches for neighbourhood identification, enabling high flexibility and versatility to address a variety of biological questions. Once identified, Kandinsky applies neighbourhoods for downstream studies, including proximity-based cell grouping for functional comparisons, spatial co-localisation and dispersion, and identification of hot and cold expression areas within the tissue. We apply Kandinsky to transcriptomic and proteomic data from different spatial technologies to showcase how it can reveal functional interactions between cells across multiple biological contexts. Availability and implementationKandinsky is freely available as an R package at https://github.com/ciccalab/Kandinsky.

bioinformatics↗

HNRNPA2B1 controls an unfolded protein response-related prognostic gene signature in prostate cancer

HNRNPA2B1 is associated with prostate cancer (PC) disease aggressiveness and underlies pro-tumourigenic cellular stress responses. By analysing >500 PC transcriptomes, we reveal that HNRNPA2B1 over-expression is associated with poor patient prognosis and stress response pathways. These include the "protein processing in the endoplasmic reticulum" (ER) pathway, which incorporates the unfolded protein response (UPR). By RNA-sequencing of HNRNPA2B1-depleted cells PC cells, we identified HNRNPA2B1-mediated down-regulation of UPR genes including the master ER-stress sensor IRE1, which induces ER proteostasis. Consistent with IRE1 down-regulation in HNRNPA2B1-depleted cells, we observed reduced splicing of the IRE1-target and key UPR effector XBP1s. Furthermore, HNRNPA2B1 depletion up-regulates expression of the IRE1-dependent decay (RIDD) target gene BLOC1S1, which is degraded by activated IRE1. We identify a HNRNPA2B1-IRE1-XBP1-controlled four gene prognostic biomarker signature (HIX) which classifies a subgroup of primary PC patients at high risk of disease relapse. Pharmacological targeting of IRE1 attenuated HNRNAPA2-driven PC cell growth. Taken together, our data reveal a putative novel mechanism of UPR activation in PC by HNRNPA2B1, which may promote an IRE1-dependent yet potentially-targetable recurrent disease phenotype.

cancer biology↗

Dysregulation of splicing-related proteins in prostate cancer is controlled by FOXA1

Prostate cancer (PCa) is genomically driven by dysregulation of transcriptional networks involving the transcriptional factors (TFs) FOXA1, ERG, AR, and HOXB13. However, the role of these specific TFs in the regulation of alternative pre-mRNA splicing (AS), which is a proven therapeutic vulnerability for cancers driven by the TF MYC, is not described. Using transcriptomic datasets from PCa patients, we tested for an association between expression of FOXA1, ERG, AR, HOXB13, and MYC, and genes involved in AS - termed splicing-related proteins (SRPs), which have pleiotropic roles in RNA metabolism. We identified FOXA1 as the strongest predictor of dysregulated SRP gene expression, which was associated with PCa disease relapse after treatment. Subsequently, we selected a subset of FOXA1-binding and actively-transcribed SRP genes that phenocopy the FOXA1 dependency of PCa cells, and confirmed in vitro via knockdown and over-expression that FOXA1 regulates SRP gene expression. Finally, we demonstrated the persistence of a FOXA1-SRP gene association in treatment-relapsed castration-resistant PCa (CRPCa) patients. Our data demonstrate, for the first time, that FOXA1 controls dysregulated SRP gene expression, which is associated with poor PCa patient outcomes. Analogous to MYC-driven cancers, our findings implicate the therapeutic targeting of SRPs and AS in FOXA1-overexpressing PCa.

cancer biology↗

Patient-specific detection of cancer genes reveals recurrently perturbed processes in esophageal adenocarcinoma

The identification of somatic alterations with a cancer promoting role is challenging in highly unstable and heterogeneous cancers, such as esophageal adenocarcinoma (EAC). Here we developed a machine learning algorithm to identify cancer genes in individual patients considering all types of damaging alterations simultaneously (mutations, copy number alterations and structural rearrangements). Analysing 261 EACs from the OCCAMS Consortium, we discovered a large number of novel cancer genes that, together with well-known drivers, help promote cancer. Validation using 107 additional EACs confirmed the robustness of the approach. Unlike known drivers whose alterations recur across patients, the large majority of the newly discovered cancer genes are rare or patient-specific. Despite this, they converge towards perturbing cancer-related processes, including intracellular signalling, cell cycle regulation, proteasome activity and Toll-like receptor signalling. Recurrence of process perturbation, rather than individual genes, divides EACs into six clusters that differ in their molecular and clinical features and suggest patient stratifications for personalised treatments. By experimentally mimicking or reverting alterations of predicted cancer genes, we validated their contribution to cancer progression and revealed EAC acquired dependencies, thus demonstrating their potential as therapeutic targets.

cancer biology↗